On Tuesday, May 31, AVAC and partners held Prospects, the third webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the what we have learned, why it matters and what it means. They looked at recent results in HIV vaccine research and implications for the future, unpacked results from Uhambo and Imbokodo trials and talked about the implications for the current pipeline of products.
Moderators:
- Stacey Hannah, AVAC’s Director of Research Engagement
- Bill Snow, AVAC Senior Advisor